A twin study of the etiology of prolonged fatigue and immune activation

Twin Research

Volumn 4, Issue 2, 2001, Pages 94-102

  Hickie, Ian B ^a   Bansal, Amolak S ^b   Kirk, Katherine M ^c,d   Lloyd, Andrew R ^a   Martin, Nicholas G ^d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST HELIER HOSPITAL   (United Kingdom)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; DISTRESS SYNDROME; DIZYGOTIC TWINS; ENVIRONMENTAL FACTOR; FEMALE; GENETIC MODEL; GENETIC REGULATION; HEREDITY; HUMAN; IMMUNE RESPONSE; IMMUNITY; INFECTION; MALE; MENTAL STRESS; MONOZYGOTIC TWINS; PRIORITY JOURNAL; RISK FACTOR; SELF REPORT; STATISTICAL MODEL; TWINS;

AGE FACTORS; ANALYSIS OF VARIANCE; DISEASES IN TWINS; ENVIRONMENT; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; IMMUNITY, CELLULAR; MALE; RISK FACTORS; SEX FACTORS; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 0035006624     PISSN: 13690523     EISSN: None     Source Type: Journal    
DOI: 10.1375/1369052012209     Document Type: Article

References (73)

1. Serum soluble CD23 but not IL8, IL10, GM-CSF or IFN-gamma is elevated in patients with hepatitis C infection
2. Serum soluble CD23 in patients with hypogammaglobulinaemia
3. Variations in serum sCD23 in conditions with either enhanced humoral or cell-mediated immunity
4. Soluble CD23 levels are elevated in the serum of patients with primary Sjögren's syndrome and systemic lupus erythematosus
5. Prevalence of fatigue and chronic fatigue syndrome in a primary care practice
6. Psychological and somatic determinants of impaired immunity
7. The relationship between fatigue, psychological and immunological variables in acute infectious illness
8. Psychiatric status and 9 year mortality data in the New Haven Epidemiologic Catchment Area Study
9. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection
10. The chronic fatigue twin registry: Method of construction, composition, and zygosity assignment
11. Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome
12. Cognitive behavior therapy for chronic fatigue syndrome: A randomized controlled trial
13. Expression, structure and function of the CD23 antigen
14. Is disabling fatigue in childhood influenced by genes?
15. The chronic fatigue syndrome: A comprehensive approach to its definition and study
16. CD23 and B cell activation
17. Screening for prolonged fatigue syndromes: Statistical and longitudinal validation of the SOFA scale
18. Excess mortality of mental disorder
19. Biological basis of the behavior of sick animals
20. Genetic and environmental contributions to alcohol dependence risk in a national twin sample: Consistency of findings in women and men
21. Psychoticism as a dimension of personality: A multivariate genetic test of Eysenck and Eysenck's psychoticism construct
22. Delayed-type hypersensitivity skin testing: Normal values in the Australian population
23. Complex genetic and environmental relationships between psychological distress, fatigue and immune functioning: A twin study
24. 'SPHERE: A National Depression Project'. I. Development of a brief screening instrument for common mental disorders in primary care
25. Reviving the diagnosis of neurasthenia
26. Impaired in vivo immune responses in patients with melancholia
27. Fatigue in selected primary care settings: Sociodemographic and psychiatric correlates
28. Unique genetic and environmental determinants of prolonged fatigue: A twin study
29. The temporal stability and co-morbidity of prolonged fatigue: A longitudinal study in primary care
30. Are cytokines associated with neuropsychiatric syndromes in humans?
31. Can the chronic fatigue syndrome be defined by distinct clinical features?
32. Chronic fatigue syndrome: Current perspectives on evaluation and management
33. Why are somatoform disorders so poorly recognized and treated?
34. Somatic distress: Developing more integrated concepts
35. Neuropeptide Y and natural killer cell activity: Findings in depression and Alzheimer caregiver stress
36. Reduction of immune function in life stress and depression
37. A community-based study of chronic fatigue syndrome
38. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey
39. Fatigue as related to anxiety and depression in a community-based sample of twins aged over 50
40. Prolonged fatigue, anxiety and depression: Exploring relationships in a primary care sample
41. Cytokine levels in serum and cerebrospinal fluid in patients with chronic fatigue syndrome and control subjects
42. Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression
43. Chronic fatigue syndrome
44. Chronic fatigue syndrome: Current concepts of pathogenesis and treatment
45. Immunological abnormalities in the chronic fatigue syndrome
46. The pharmacology and toxicology of the interferons: An overview
47. Protracted debility and fatigue after acute Q fever
48. The inheritance of scholastic abilities in a sample of twins. I. Ascertainments of the sample and diagnosis of zygosity
49. Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers
50. Neurasthenia in a longitudinal cohort study of young adults
51. High titers of anti-Epstein-Barr virus DNA polymerase are found in patients with severe fatiguing illness
52. Developmental factors modify stress ulcer incidence in a stress-susceptible rat strain
53. Population based study of fatigue and psychological distress
54. MMPI profiles of patients with chronic fatigue syndrome
55. Changing epidemiology of Ross River virus disease in South Australia
56. Cognitive behavior therapy for the chronic fatigue syndrome: A randomized controlled trial
57. Persisting complaints attributed to chronic Lyme disease: Possible mechanisms and implications for management
58. The epidemiology of chronic fatigue in San Francisco
59. Studies of herpesvirus infection in chronic fatigue syndrome
60. Serologic and virologic epidemiology of Epstein-Barr virus: Relevance to chronic fatigue syndrome
61. Consequences of stress: A multiplicative function of health status
62. Fatigue and psychiatric disorder: Different or the same?
63. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome
64. Chronic fatigue syndrome: An immunological perspective
65. Safety profile of interferon-alpha therapy
66. The validity and reliability of the fatigue syndrome that follows glandular fever
67. The existence of a fatigue syndrome after glandular fever